Clinical trial
Predictive Value of NT-proBNP on Major Adverse Cardiovascular Events in Patients With Acute Coronary Syndrome During a 6-month Follow-up
NCT06569511 is registered in ClinicalTrials.gov with Haseki Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Value of NT-proBNP on Major Adverse Cardiovascular Events in Patients With Acute Coronary Syndrome During a 6-month Follow-up
- Lead sponsor
- Haseki Training and Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2023
- Completion date
- March 1, 2024
- Enrollment
- 241 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, major adverse cardiac events, non-st-segment elevation myocardial infarction (nstemi), st-segment elevation myocardial infarction (stemi)